⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001996097

Thomas Brian C.

Reports to the SEC for 1 company · EMERYVILLE, CA

Transactions

7

Companies

1

Filings

5

CIK

0001996097

Forms 4 and 5

Insider transactions

7 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-05	MGXMetagenomi Therapeutics, Inc.S Sale	Director	SSale	−3,830 sh	$1.77	−$6,786.377	2,510,960
2025-09-05	MGXMetagenomi Therapeutics, Inc.S Sale	Director	SSale	−2,701 sh	$1.81	−$4,888.81	2,514,790
2025-06-06	MGXMetagenomi Therapeutics, Inc.S Sale	Director	SSale	−10.8K sh	$1.75	−$18.9K	2,517,491
2025-04-01	MGXMetagenomi Therapeutics, Inc.A Award	Director	AAward	+32K sh	—	—	2,528,276
2025-04-01	MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+196K sh	—	—	196,000
2024-04-01	MGXMetagenomi Therapeutics, Inc.A Award	Director	AAward	+119K sh	—	—	2,496,276
2024-04-01	MGXMetagenomi Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+500K sh	—	—	500,323

Recent filings

5

Accepted (ET)
Dec 84
Thomas Brian C.0001193125-25-310971
SEC(opens sec.gov)
Dec 14
Thomas Brian C.0001193125-25-304221
SEC(opens sec.gov)
Jun 94
Thomas Brian C.0000950170-25-083947
SEC(opens sec.gov)
Apr 34
Thomas Brian C.0000950170-25-050102
SEC(opens sec.gov)
Apr 34
Thomas Brian C.0000950170-24-041449
SEC(opens sec.gov)

Companies

1

Metagenomi Therapeutics, Inc.DirectorMGX

Address

C/O METAGENOMI, INC. 5959 HORTON STREET, 7TH FLOOR

EMERYVILLE, CA, 94608